Zurich Insurance Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Zurich Insurance Group's VRTX Position: Q2 2026 in Review

Zurich Insurance Group reduced its Vertex Pharmaceuticals (VRTX) stake by 2.3% in Q2 2026, selling an estimated $456K and leaving 43,589 shares worth $21.7M. The position accounts for 0.15% of the portfolio, ranked #152.

Zurich Insurance Group first reported a position in VRTX in Q2 2016 and has held it in 25 quarters since. The position peaked at $104M in Q2 2023. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• Zurich Insurance Group held 43,589 shares of Vertex Pharmaceuticals worth $21.7M as of Q2 2026.
• Zurich Insurance Group sold 1,029 Vertex Pharmaceuticals shares in Q2 2026, an estimated $456K.
• Vertex Pharmaceuticals made up 0.15% of Zurich Insurance Group's portfolio in Q2 2026, its #152 holding.
• Zurich Insurance Group first reported a position in Vertex Pharmaceuticals in Q2 2016 and has held it in 25 quarters since.
• Zurich Insurance Group's Vertex Pharmaceuticals position peaked at $104M in Q2 2023.
• 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Zurich Insurance Group's 13F filing for Q2 2026, filed 14 Aug 2026.